Movatterモバイル変換

[0]ホーム
URL:

ECSP056112A - RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT - Google Patents

RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT

Info

Publication number
ECSP056112A
ECSP056112AECSP056112AECSP056112AEC SP056112 AECSP056112 AEC SP056112AEC SP056112 AECSP056112 AEC SP056112AEC SP056112 AECSP056112 AEC SP056112A
Authority
EC
Ecuador
Prior art keywords
ganglioside
glycolyl
glicolil
diagnosis
recombinant antibodies
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Navarro Lourdes Tatiana Roque
De Acosta Del Rio Cristina Maria Mateo
Gonzalez Mabel Rodriguez
Dorantes Gertrudis Rojas
Perez Ariel Talavera
Frias Ernesto Moreno
Original Assignee
De Acosta Del Rio Cristina Maria Mateo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Acosta Del Rio Cristina Maria MateofiledCriticalDe Acosta Del Rio Cristina Maria Mateo
Priority to ECSP056112priorityCriticalpatent/ECSP056112A/en
Publication of ECSP056112ApublicationCriticalpatent/ECSP056112A/en

Links

Landscapes

Abstract

Translated fromSpanish

La presente invención se relaciona fundamentalmente con la producción de inmunoglobulinas menos inmunogénicas por la vía de la ingeniería genética, y más específicamente con un anticuerpo monoclonal que reconoce antígenos que contienen el gangliósido N-glicolil GM3 y no otros gangliósidos del tipo N-glicolil o N-acetil, ni a los glicolípidos sulfatados. Más específicamente la presente invención se relaciona con las secuencias peptídicas que codifican un anticuerpo monoclonal recombinante contra el gangliósido n-glicolil GM3, o fragmentos derivados del mismo y composiciones farmacéuticas conteniendo dicho anticuerpo o sus fragmentos y su uso tanto diagnostico o terapéutico en cáncer de mama y melanoma.The present invention relates primarily to the production of less immunogenic immunoglobulins by genetic engineering, and more specifically to a monoclonal antibody that recognizes antigens containing the ganglioside N-glycolyl GM3 and no other gangliosides of the N-glycolyl or N type -acetyl, or sulfated glycolipids. More specifically, the present invention relates to the peptide sequences encoding a recombinant monoclonal antibody against the n-glycolyl GM3 ganglioside, or fragments derived therefrom and pharmaceutical compositions containing said antibody or its fragments and its diagnostic or therapeutic use in breast cancer. and melanoma

ECSP0561122005-10-212005-10-21 RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENTECSP056112A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
ECSP056112ECSP056112A (en)2005-10-212005-10-21 RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
ECSP056112ECSP056112A (en)2005-10-212005-10-21 RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT

Publications (1)

Publication NumberPublication Date
ECSP056112Atrue ECSP056112A (en)2006-04-19

Family

ID=40203023

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ECSP056112ECSP056112A (en)2005-10-212005-10-21 RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT

Country Status (1)

CountryLink
EC (1)ECSP056112A (en)

Similar Documents

PublicationPublication DateTitle
UY28289A1 (en) RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIASNOSTIC AND TUMOR TREATMENT
MX2019015742A (en)Novel t cell receptors and immune therapy using the same.
BR112018014615A2 (en) ror1 antibody compositions and related methods
HK1257730A1 (en)Anti-despr monoclonal antibody targeted therapy and imaging for cancer and stroke
MX2019004692A (en)Anti-human 4-1 bb antibodies and use thereof.
MX2020004741A (en)Novel engineered t cell receptors and immune therapy using the same.
MX2010005022A (en)Antibodies that bind human dendritic and epithelial cell 205 (dec-205).
HK1253507A1 (en) Anti-ROR1 antibody
AR071304A1 (en) ANTIBODIES ANTI CD151 (FLBR MEMBRANE PROTEIN. OF TETRASPANINS) USEFUL FOR CANCER TREATMENT
GT201100269A (en) IMMUNOCONJUGADOS OF ANTIMESOTELINA AND USES OF THE SAME
CU20130130A7 (en) ANTIBODIES TYPE RECEIVER OF SPECIFIC T-CELLS FOR A WT1 PEPTIDE PRESENTED BY HLA-A2
AR108663A1 (en) ANTIBODIES AGAINST SINUCLEINE AND ITS USES
GT201300186A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HUMAN ANTIBODIES AGAINST PCSK9
AR076668A1 (en) SPECIFIC ANTIBODIES FOR DKK-1 AND ITS USES
PE20080663A1 (en) TUMOR THERAPY WITH A COMBINATION OF ANTI-HER2 ANTIBODIES
PE20081625A1 (en) IL-17 A RECEPTOR ANTIGEN BINDING PROTEINS
EP4477270A3 (en)Methods and compositions for dosing of allogeneic chimeric antigen receptor t cells
MX2016014000A (en)Igf-1r antibody and its use as addressing vehicle for the treatment of cancer.
PE20020972A1 (en) RECOMBINANT ANTIBODIES ASSOCIATED WITH GANGLIOSIDES
UY37630A (en) PHARMACEUTICAL COMBINATION, KIT, GUEST CELL THAT PRODUCES IT AND ITS USE IN METHODS FOR CANCER TREATMENT
MX2020009879A (en) ANTI-IL-27 ANTIBODIES AND THEIR USES.
NZ750948A (en)Anti-gp73 antibodies and immunoconjugates
ECSP056112A (en) RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT
ATE525401T1 (en) MHC CLASS I AND II PEPTIDE ANTIGENS DERIVED FROM TUMOR ANTIGEN 5T4
AR077941A1 (en) ANTIBODIES AGAINST OSTEOPONTINE
[8]ページ先頭
©2009-2025 Movatter.jp